Global Leukapheresis Devices Market, By Type (Apheresis Devices, Leukapheresis Columns and Cell Separators and Leukoreduction Filters), Application (Research Applications and Therapeutic Applications), End User (Blood Component Providers and Blood Centres, Academic and Research Institutes, Pharmaceutical and Biotechnology Companies and Hospitals and Transfusion Centres), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2028
Market Analysis and Insights : Global Leukapheresis Devices Market
Data Bridge Market Research analyses that the leukapheresis devices market will exhibit a CAGR of around 41.18% for the forecast period of 2021-2028. Rising prevalence of leukaemia and blood related disorders, increased focus on research and development proficiencies in regards to medical devices and on the adoption of advanced healthcare technologies, growing rate of geriatric population and rising expenditure for the development of healthcare infrastructure especially in the developing economies are the major factors attributable to the growth of leukapheresis devices market. Therefore, the market value, which was USD 24.46 million in 2020, would rocket up to USD 36.54 million by 2028.
Leukaemia is a medical procedure of separating white blood cells from a sample of blood. The procedure is undergone to reduce the quantity of white blood cells in patients having hematological malignancies. Therefore, leukapheresis devices are the medical devices that are used to facilitate this procedure.
Upsurge in the demand for leukopaks in clinical researches is one of the major factors fostering the growth of the market. Growth in the number of activities associated with blood donations coupled with growing innovations and advancements of technologies is another market growth determinant. Rising health awareness among the individuals, growing approvals for processes of isolating white blood corpuscles (WBC) and rising medical tourism are other important factors that will further generate lucrative market growth opportunities.
However, improper and unfavourable reimbursement scenario in the developing and underdeveloped economies will derail the market growth rate. Also, high costs of therapeutic leukapheresis and cellular therapies and stringent donor recruitment criteria will further pose challenges for the market. Dearth of skilled professionals in the backward economies and rising concerns related to blood transfusion will also hamper the market growth rate.
This leukapheresis devices market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on leukapheresis devices market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Leukapheresis Devices Market Scope and Market Size
The leukapheresis devices market is segmented on the basis of type, application and end user. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of type, the leukapheresis devices market is segmented into apheresis devices, leukapheresis columns and cell separators and leukoreduction filters.
- Based on application, the leukapheresis devices market is segmented into research applications and therapeutic applications.
The end user segment of leukapheresis devices market is segmented into blood component providers and blood centers, academic and research institutes, pharmaceutical and biotechnology companies and hospitals and transfusion centers.
Leukapheresis Devices Market Country Level Analysis
The leukapheresis devices market is analysed and market size insights and trends are provided by country, type, application and end user as referenced above.
The countries covered in the leukapheresis devices market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the leukapheresis devices market in terms of market share and market revenue and will continue to flourish its dominance during the forecast period. This is because of the increasing funding for research and development activities and growing occurrence of lukaemia. Asia-Pacific on the other hand is projected to exhibit the highest growth rate during the forecast period owing to the growing number of private biotechnology companies and ever-rising geriatric population.
The country section of the leukapheresis devices market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare infrastructure growth installed base and new technology penetration
The leukapheresis devices market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for leukapheresis devices market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the leukapheresis devices market. The data is available for historic period 2010 to 2019.
Competitive Landscape and Leukapheresis Devices Market Share Analysis
The leukapheresis devices market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to leukapheresis devices market.
The major players covered in the leukapheresis devices market report are Asahi Kasei Medical Co. Ltd, Haemonetics Corporation, TERUMO BCT INC., STEMCELL Technologies Inc., Fresenius SE & Co. KGaA, HemaCare, B. Braun Melsungen AG, Caltag Medsystems Limited, AllCells, StemExpress, PPA, Cellero, Precision for Medicine, Inc., The Intelligent Tissue Group Lonza, BioIVT, Lmb Technologie GmbH, Grifols, S.A, and Kaneka Medical Europe N.V. among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
SKU-